Race to be the first widely distributed protein subunit Covid-19 vaccine heats up with Vaxine nipping at Novavax’s heels.
Turkey is getting its first locally produced mAb via an Iranian biosimilars marker and the $100 million plant it built there. CinnaGen Pharmaceuticals has opened the plant in Çerkezköy, in northwestern Turkey's Tekirda?, the Daily Sabah reports. Details were few but the CinnaGen CEO ?laç Ferhat Far?i told the publication that American scientists were among its employees.
AryoGen Pharmed has become the first manufacturer of monoclonal antibody (MAb) biologics in the Middle East and North Africa (MENA) region to receive good manufacturing practice (GMP) certification from the European Medicines Agency (EMA).
A new name is now listed among the member companies of the official trade association for the European generic, biosimilar and value-added pharmaceutical industries.
CinnaGen CEO not holding back in ambition to be a global player